ArticleProceedings of the National Academy of Sciences of the United States of America2026

Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma.

Zhipeng Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.